骨髓间充质基质细胞中泛素结合酶E2O过表达部分减轻急性髓系白血病进展
该研究探讨骨髓间充质基质细胞(BM-MSCs)中泛素结合酶E2O(UBE2O)对急性髓系白血病(AML)的影响。混合谱系白血病-AF9(MLL-AF9)诱导的AML小鼠来源MSCs增殖能力高于野生型小鼠来源MSCs,且UBE2O表达下调;在AML来源MSCs中过表达UBE2O后,MSCs生长能力降低并伴核因子κB亚基1(NF-κB)通路失活。体外共培养显示UBE2O过表达MSCs通过直接接触抑制AML细胞增殖并促进其凋亡;体内实验显示白血病负荷降低、AML小鼠总生存期延长,骨髓、脾、肝和外周血中白血病细胞播散减少,皮下成瘤实验中UBE2O过表达MSCs组肿瘤生长亦受抑制。
要点
- MLL-AF9诱导的AML小鼠来源MSCs较野生型小鼠来源MSCs增殖能力更高,且UBE2O表达下调。
- UBE2O过表达使AML来源MSCs生长能力降低,并伴NF-κB通路失活。
- UBE2O过表达MSCs经直接接触抑制AML细胞增殖、促进凋亡,并减轻白血病负荷、延长AML小鼠生存。
核心结论
- UBE2O在MLL-AF9诱导的AML小鼠来源MSCs中低表达;在MSCs中过表达UBE2O可通过NF-κB通路失活抑制其增殖,从而抑制AML;该研究为基于骨髓微环境的治疗策略提供理论依据。
研究设计与样本
- 研究采用MLL-AF9诱导的AML小鼠来源MSCs与野生型小鼠来源MSCs进行比较,并进行UBE2O过表达、体外共培养、体内实验及皮下成瘤实验。
主要发现
- MLL-AF9诱导的AML小鼠来源MSCs较野生型小鼠来源MSCs增殖能力更高,且UBE2O表达下调。
- AML来源MSCs过表达UBE2O后生长能力降低,并伴NF-κB通路失活。
- 体外共培养显示UBE2O过表达MSCs通过直接接触抑制AML细胞增殖并促进其凋亡。
- 体内实验显示白血病负荷降低、AML小鼠总生存期延长,骨髓、脾、肝和外周血中白血病细胞播散减少。
- 皮下成瘤实验显示UBE2O过表达MSCs组肿瘤生长受抑制。
临床怎么用
- 原文结论为UBE2O过表达经NF-κB通路失活抑制MSCs增殖并抑制AML,为基于骨髓微环境的治疗策略提供理论依据,原文未据此给出临床推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bone marrow mesenchymal stromal cells (BM-MSCs) are implicated in the pathogenesis of acute myeloid leukaemia (AML). However, due to the high heterogeneity of AML the mechanism underlying the cross-talk between MSCs and leukaemia cells is not well understood. We found that mixed-lineage leukaemia-AF9 (MLL-AF9)-induced AML mice-derived MSCs had higher proliferative viability compared to wild-type mice-derived MSCs with ubiquitin-conjugating enzyme E2O (Ube2o) down-regulation. After overexpression of UBE2O in AML-derived MSCs, the growth capacity of MSCs was reduced with nuclear factor kappa B subunit 1 (NF-κB) pathway deactivation. In vitro co-culture assay revealed that UBE2O-overexpression MSCs suppressed the proliferation and promoted apoptosis of AML cells by direct contact. In vivo results revealed that the leukaemia burden was reduced and the overall survival of AML mice was prolonged, with decreased dissemination of leukaemia cells in BM, spleen, liver and peripheral blood. Additionally, subcutaneous tumorigenesis revealed that tumour growth was also suppressed in the UBE2O-overexpression MSCs group. In conclusion, UBE2O was expressed at a low level in MLL-AF9-induced AML mice-derived MSCs. Overexpression of UBE2O in MSCs suppressed their proliferation through NF-κB pathway deactivation, which resulted in AML suppression. Our study provides a theoretical basis for a BM microenvironment-based therapeutic strategy to control disease progression.
引用
- Tian C, Chen Z, Wang L, et al. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression. Br J Haematol. 2022. PMID: 36345807. doi:10.1111/bjh.18541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。